Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study

Clinical trial NCT05056194 · WITHDRAWN

Trial details

NCT number: NCT05056194
Sponsor: XWPharma
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease Excessive Daytime Somnolence

Start date: 2021-11-01
Primary completion: 2022-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.